ACS Medicinal Chemistry Letters · 2020 · 15 citations · 26 references
MedicineMedicinal ChemistryPharmacologyMolecular NeurobiologyMolecular NeuroscienceNeuropharmacologyBlood-brain Barrier PharmacologyEnzyme InhibitionNeurochemical PharmacologyNeurodegenerative Disease PharmacologyNeuroprotectionNeurotransmissionAmyloid Beta PeptidesAmyloid InhibitionBeta Secretase InhibitionFluorescence Correlation SpectroscopyGamma Secretase InhibitionGamma-secretase ProcessingOligomerizationProteolysis Products
Tafamidis, 1, a potent transthyretin kinetic stabilizer, weakly inhibits the γ-secretase enzyme in vitro. We have synthesized four amide derivatives of 1. These compounds reduce production of the Aβ peptide in N2a695 cells but do not inhibit the γ-secretase enzyme in cell-free assays. By performing fluorescence correlation spectroscopy, we have shown that TTR inhibits Aβ oligomerization and that addition of tafamidis or its amide derivative does not affect TTR’s ability to inhibit Aβ oligomerization. The piperazine amide derivative of tafamidis (1a) efficiently penetrates and accumulates in mouse brain and undergoes proteolysis under physiological conditions in mice to produce tafamidis.
26
Holly D. Oakley, Sarah L. Cole, Sreemathi Logan et al. · Journal of Neuroscience · 2006 · 3.6K citations · Full text
Cell Sensitivity Assays: The MTT Assay
Johan van Meerloo, Gertjan J.L. Kaspers, Jacqueline Cloos · Methods in molecular biology · 2011 · 2.5K citations